CI
Cytokinetics Incorporated
CYTK· Health Care· BiotechnologyS&P 400
Close · 16/09/2026
69.39
1D
+0.12%52-week range
47.22 – 88.31
Volume
22,11,800.00
Price history
CYTK
17/08/2026 to 16/09/2026
O 69.52 H 70.68 L 68.67
1W-6.37%
1M-8.54%
3M-7.74%
6M+11.69%
1Y+40.35%
3Y+99.80%
5Y+122.98%
MAX+274.27%
Fundamentals
as of 16/09/2026- Market cap
- $9.65B
- Shares out
- 139.02M
- P/E (forward)
- -16.34
- EPS (trailing)
- -6.43
- Beta
- 0.36
- Profit margin
- -1321.12%
- P/B
- -58.18
SEC financial statements
56 quarterly and 27 annual periods through 30/06/2026.
Details
- Ticker
- CYTK
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
2 filers · 0 on watchlist · 3 buys · 1 sell · D: 2 · R: 2
- 30/06/2026Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 09/10/2025Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 17/06/2025Lisa McClainSellCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000